METabolism After Orthopedic Surgery
Sponsor
Istituto Ortopedico Galeazzi (Other)
Overall Status
Recruiting
CT.gov ID
NCT05864833
Collaborator
(none)
51
1
11.9
4.3
Study Details
Study Description
Brief Summary
This prospective observational study evaluates changes in resting basal metabolic rate in 51 adult patients undergoing elective major orthopedic surgery (hip, knee, or spine surgery).
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
51 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Study of Energy Metabolism Modifications in Patients Undergoing Orthopedic Surgery
Anticipated Study Start Date
:
Jun 6, 2023
Anticipated Primary Completion Date
:
Jun 12, 2023
Anticipated Study Completion Date
:
Jun 1, 2024
Outcome Measures
Primary Outcome Measures
- Changes in basal energy expenditure [Day before surgery and first day after surgery]
Changes in the basal metabolic rate (kcal) evaluated before and after major orthopedic surgery
Eligibility Criteria
Criteria
Ages Eligible for Study:
55 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Age ≥55
-
Male and female gender
-
Major elective orthopedic surgery (hip, knee, spinal)
-
Signature of the informed consent
Exclusion Criteria:
-
Inability to follow the study protocol
-
Neuropsychiatric disease, developmental disorders
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | IRCCS Istituto Ortopedico Galeazzi | Milan | Italy |
Sponsors and Collaborators
- Istituto Ortopedico Galeazzi
Investigators
- Principal Investigator: Matteo Briguglio, IRCCS Istituto Ortopedico Galeazzi
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Istituto Ortopedico Galeazzi
ClinicalTrials.gov Identifier:
NCT05864833
Other Study ID Numbers:
- METOS (PI: M Briguglio)
- L4176
First Posted:
May 18, 2023
Last Update Posted:
May 18, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: